microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients

go back to reference L.H. Looijenga, Human testicular (non)seminomatous germ cell tumours: The clinical implications of recent pathobiological insights. J Pathol 218, 146–162 (2009)CrossRefPubMed L.H. Looijenga, Human testicular (non)seminomatous germ cell tumours: The clinical implications of recent pathobiological insights. J Pathol 218, 146–162 (2009)CrossRefPubMed

go back to reference B. Trabert, J. Chen, S.S. Devesa, F. Bray, K.A. McGlynn, Persistent organic pollutants (POPs) and fibroids: Results from the ENDO study. Andrology 3, 4–12 (2015)CrossRefPubMed B. Trabert, J. Chen, S.S. Devesa, F. Bray, K.A. McGlynn, Persistent organic pollutants (POPs) and fibroids: Results from the ENDO study. Andrology 3, 4–12 (2015)CrossRefPubMed

go back to reference A. Horwich, J. Shipley, R. Huddart, Testicular germ-cell cancer. Lancet 367, 754–765 (2006)CrossRefPubMed A. Horwich, J. Shipley, R. Huddart, Testicular germ-cell cancer. Lancet 367, 754–765 (2006)CrossRefPubMed

go back to reference T.M. Ulbright, B. Balzer, WHO classification of tumours of the Urinary System and Male Genital Organs. Fourth edition, in IARC WHO Classification of Tumours, No 8, ed. by H. Moch, Humphrey, P.A., Ulbright, T.M., Reuter, V.E. (Lyon: IARC Press, 2016), p. 189–226 T.M. Ulbright, B. Balzer, WHO classification of tumours of the Urinary System and Male Genital Organs. Fourth edition, in IARC WHO Classification of Tumours, No 8, ed. by H. Moch, Humphrey, P.A., Ulbright, T.M., Reuter, V.E. (Lyon: IARC Press, 2016), p. 189–226

go back to reference D.M. Berney, L.H. Looijenga, M. Idrees, J.W. Oosterhuis, E. Rajpert-De Meyts, T.M. Ulbright, N.E. Skakkebaek, Germ cell neoplasia in situ (GCNIS): evolution of the current nomenclature for testicular pre-invasive germ cell malignancy. Histopathology 69, 7–10 (2016) D.M. Berney, L.H. Looijenga, M. Idrees, J.W. Oosterhuis, E. Rajpert-De Meyts, T.M. Ulbright, N.E. Skakkebaek, Germ cell neoplasia in situ (GCNIS): evolution of the current nomenclature for testicular pre-invasive germ cell malignancy. Histopathology 69, 7–10 (2016)

go back to reference J.W. Oosterhuis, L.H. Looijenga, Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5, 210–222 (2005)CrossRefPubMed J.W. Oosterhuis, L.H. Looijenga, Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5, 210–222 (2005)CrossRefPubMed

go back to reference L. Boublikova, T. Buchler, J. Stary, J. Abrahamova, J. Trka, Molecular biology of testicular germ cell tumors: Unique features awaiting clinical application. Crit rev Oncol Hematol 89, 366–385 (2014)CrossRefPubMed L. Boublikova, T. Buchler, J. Stary, J. Abrahamova, J. Trka, Molecular biology of testicular germ cell tumors: Unique features awaiting clinical application. Crit rev Oncol Hematol 89, 366–385 (2014)CrossRefPubMed

go back to reference N. Vasdev, A. Moon, A.C. Thorpe, Classification, epidemiology and therapies for testicular germ cell tumours. Int J Dev Biol 57, 133–139 (2013)CrossRefPubMed N. Vasdev, A. Moon, A.C. Thorpe, Classification, epidemiology and therapies for testicular germ cell tumours. Int J Dev Biol 57, 133–139 (2013)CrossRefPubMed

go back to reference J. Beyer, P. Albers, R. Altena, J. Aparicio, C. Bokemeyer, J. Busch, R. Cathomas, E. Cavallin-Stahl, N.W. Clarke, J. Classen, G. Cohn-Cedermark, A.A. Dahl, G. Daugaard, U. De Giorgi, M. De Santis, M. De Wit, R. De Wit, K.P. Dieckmann, M. Fenner, K. Fizazi, A. Flechon, S.D. Fossa, J.R. Germa Lluch, J.A. Gietema, S. Gillessen, A. Giwercman, J.T. Hartmann, A. Heidenreich, M. Hentrich, F. Honecker, A. Horwich, R.A. Huddart, S. Kliesch, C. Kollmannsberger, S. Krege, M.P. Laguna, L.H. Looijenga, A. Lorch, J.P. Lotz, F. Mayer, A. Necchi, N. Nicolai, J. Nuver, K. Oechsle, J. Oldenburg, J.W. Oosterhuis, T. Powles, E. Rajpert-De Meyts, O. Rick, G. Rosti, R. Salvioni, M. Schrader, S. Schweyer, F. Sedlmayer, A. Sohaib, R. Souchon, T. Tandstad, C. Winter, C. Wittekind, Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol 24, 878–888 (2013)CrossRefPubMed J. Beyer, P. Albers, R. Altena, J. Aparicio, C. Bokemeyer, J. Busch, R. Cathomas, E. Cavallin-Stahl, N.W. Clarke, J. Classen, G. Cohn-Cedermark, A.A. Dahl, G. Daugaard, U. De Giorgi, M. De Santis, M. De Wit, R. De Wit, K.P. Dieckmann, M. Fenner, K. Fizazi, A. Flechon, S.D. Fossa, J.R. Germa Lluch, J.A. Gietema, S. Gillessen, A. Giwercman, J.T. Hartmann, A. Heidenreich, M. Hentrich, F. Honecker, A. Horwich, R.A. Huddart, S. Kliesch, C. Kollmannsberger, S. Krege, M.P. Laguna, L.H. Looijenga, A. Lorch, J.P. Lotz, F. Mayer, A. Necchi, N. Nicolai, J. Nuver, K. Oechsle, J. Oldenburg, J.W. Oosterhuis, T. Powles, E. Rajpert-De Meyts, O. Rick, G. Rosti, R. Salvioni, M. Schrader, S. Schweyer, F. Sedlmayer, A. Sohaib, R. Souchon, T. Tandstad, C. Winter, C. Wittekind, Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol 24, 878–888 (2013)CrossRefPubMed

go back to reference D. Vesprini, P. Chung, S. Tolan, M. Gospodarowicz, M. Jewett, M. O'Malley, J. Sweet, M. Moore, T. Panzarella, J. Sturgeon, L. Sugar, L. Anson-Cartwright, P. Warde, Utility of serum tumor markers during surveillance for stage I seminoma. Cancer 118, 5245–5250 (2012)CrossRefPubMed D. Vesprini, P. Chung, S. Tolan, M. Gospodarowicz, M. Jewett, M. O'Malley, J. Sweet, M. Moore, T. Panzarella, J. Sturgeon, L. Sugar, L. Anson-Cartwright, P. Warde, Utility of serum tumor markers during surveillance for stage I seminoma. Cancer 118, 5245–5250 (2012)CrossRefPubMed

go back to reference C.M. Sturgeon, M.J. Duffy, U.H. Stenman, H. Lilja, N. Brunner, D.W. Chan, R. Babaian, R.C. Bast Jr., B. Dowell, F.J. Esteva, C. Haglund, N. Harbeck, D.F. Hayes, M. Holten-Andersen, G.G. Klee, R. Lamerz, L.H. Looijenga, R. Molina, H.J. Nielsen, H. Rittenhouse, A. Semjonow, M. Shih Ie, P. Sibley, G. Soletormos, C. Stephan, L. Sokoll, B.R. Hoffman, E.P. Diamandis, National Academy of Clinical Biochemistry, National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin Chem 54, e11–e79 (2008)CrossRefPubMed C.M. Sturgeon, M.J. Duffy, U.H. Stenman, H. Lilja, N. Brunner, D.W. Chan, R. Babaian, R.C. Bast Jr., B. Dowell, F.J. Esteva, C. Haglund, N. Harbeck, D.F. Hayes, M. Holten-Andersen, G.G. Klee, R. Lamerz, L.H. Looijenga, R. Molina, H.J. Nielsen, H. Rittenhouse, A. Semjonow, M. Shih Ie, P. Sibley, G. Soletormos, C. Stephan, L. Sokoll, B.R. Hoffman, E.P. Diamandis, National Academy of Clinical Biochemistry, National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin Chem 54, e11–e79 (2008)CrossRefPubMed

go back to reference M. Salem, T. Gilligan, Serum tumor markers and their utilization in the management of germ-cell tumors in adult males. Expert Rev Anticancer Ther 11, 1–4 (2011) M. Salem, T. Gilligan, Serum tumor markers and their utilization in the management of germ-cell tumors in adult males. Expert Rev Anticancer Ther 11, 1–4 (2011)

go back to reference M.J. Murray, R.A. Huddart and N. Coleman, The present and future of serum diagnostic tests for testicular germ cell tumours. Nat Rev Urol 13, 715-725 (2016) M.J. Murray, R.A. Huddart and N. Coleman, The present and future of serum diagnostic tests for testicular germ cell tumours. Nat Rev Urol 13, 715-725 (2016)

go back to reference A.J. Gillis, M.A. Rijlaarsdam, R. Eini, L.C. Dorssers, K. Biermann, M.J. Murray, J.C. Nicholson, N. Coleman, K.P. Dieckmann, G. Belge, J. Bullerdiek, T. Xu, N. Bernard, L.H. Looijenga, Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: A proof of principle. Mol Oncol 7, 1083–1092 (2013)CrossRefPubMed A.J. Gillis, M.A. Rijlaarsdam, R. Eini, L.C. Dorssers, K. Biermann, M.J. Murray, J.C. Nicholson, N. Coleman, K.P. Dieckmann, G. Belge, J. Bullerdiek, T. Xu, N. Bernard, L.H. Looijenga, Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: A proof of principle. Mol Oncol 7, 1083–1092 (2013)CrossRefPubMed

go back to reference P.M. Voorhoeve, C. le Sage, M. Schrier, A.J. Gillis, H. Stoop, R. Nagel, Y.P. Liu, J. van Duijse, J. Drost, A. Griekspoor, E. Zlotorynski, N. Yabuta, G. De Vita, H. Nojima, L.H. Looijenga, R. Agami, A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124, 1169–1181 (2006)CrossRefPubMed P.M. Voorhoeve, C. le Sage, M. Schrier, A.J. Gillis, H. Stoop, R. Nagel, Y.P. Liu, J. van Duijse, J. Drost, A. Griekspoor, E. Zlotorynski, N. Yabuta, G. De Vita, H. Nojima, L.H. Looijenga, R. Agami, A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124, 1169–1181 (2006)CrossRefPubMed

go back to reference A.J. Gillis, H.J. Stoop, R. Hersmus, J.W. Oosterhuis, Y. Sun, C. Chen, S. Guenther, J. Sherlock, I. Veltman, J. Baeten, P.J. van der Spek, P. de Alarcon, L.H. Looijenga, High-throughput microRNAome analysis in human germ cell tumours. J Pathol 213, 319–328 (2007)CrossRefPubMed A.J. Gillis, H.J. Stoop, R. Hersmus, J.W. Oosterhuis, Y. Sun, C. Chen, S. Guenther, J. Sherlock, I. Veltman, J. Baeten, P.J. van der Spek, P. de Alarcon, L.H. Looijenga, High-throughput microRNAome analysis in human germ cell tumours. J Pathol 213, 319–328 (2007)CrossRefPubMed

go back to reference R.D. Palmer, M.J. Murray, H.K. Saini, S. van Dongen, C. Abreu-Goodger, B. Muralidhar, M.R. Pett, C.M. Thornton, J.C. Nicholson, A.J. Enright, N. Coleman, Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets. Cancer Res 70, 2911–2923 (2010) R.D. Palmer, M.J. Murray, H.K. Saini, S. van Dongen, C. Abreu-Goodger, B. Muralidhar, M.R. Pett, C.M. Thornton, J.C. Nicholson, A.J. Enright, N. Coleman, Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets. Cancer Res 70, 2911–2923 (2010)

go back to reference T. van Agthoven and L.H. Looijenga, Accurate primary germ cell cancer diagnosis using serum based microrna detection (ampTSmiR Test). Oncotarget. doi:10.18632/oncotarget.10867 (2016) T. van Agthoven and L.H. Looijenga, Accurate primary germ cell cancer diagnosis using serum based microrna detection (ampTSmiR Test). Oncotarget. doi:10.​18632/​oncotarget.​10867 (2016)

go back to reference K.P. Dieckmann, A. Radtke, M. Spiekermann, T. Balks, C. Matthies, P. Becker, C. Ruf, C. Oing, K. Oechsle, C. Bokemeyer, J. Hammel, S. Melchior, W. Wosniok and G. Belge, Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific new Biomarker for Germ Cell Tumours. Eur Urol 71, 213–220 (2017) K.P. Dieckmann, A. Radtke, M. Spiekermann, T. Balks, C. Matthies, P. Becker, C. Ruf, C. Oing, K. Oechsle, C. Bokemeyer, J. Hammel, S. Melchior, W. Wosniok and G. Belge, Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific new Biomarker for Germ Cell Tumours. Eur Urol 71, 213–220 (2017)

go back to reference M. Spiekermann, G. Belge, N. Winter, R. Ikogho, T. Balks, J. Bullerdiek, K.P. Dieckmann, MicroRNA miR-371a-3p in serum of patients with germ cell tumours: Evaluations for establishing a serum biomarker. Andrology 3, 78–84 (2015)CrossRefPubMed M. Spiekermann, G. Belge, N. Winter, R. Ikogho, T. Balks, J. Bullerdiek, K.P. Dieckmann, MicroRNA miR-371a-3p in serum of patients with germ cell tumours: Evaluations for establishing a serum biomarker. Andrology 3, 78–84 (2015)CrossRefPubMed

go back to reference I. Syring, J. Bartels, S. Holdenrieder, G. Kristiansen, S.C. Muller, J. Ellinger, Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer. J Urol 193, 331–337 (2015)CrossRefPubMed I. Syring, J. Bartels, S. Holdenrieder, G. Kristiansen, S.C. Muller, J. Ellinger, Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer. J Urol 193, 331–337 (2015)CrossRefPubMed

go back to reference M.J. Murray, E. Bell, K.L. Raby, M.A. Rijlaarsdam, A.J. Gillis, L.H. Looijenga, H. Brown, B. Destenaves, J.C. Nicholson, N. Coleman, A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours. Br J Cancer 114, 151–162 (2016)CrossRefPubMed M.J. Murray, E. Bell, K.L. Raby, M.A. Rijlaarsdam, A.J. Gillis, L.H. Looijenga, H. Brown, B. Destenaves, J.C. Nicholson, N. Coleman, A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours. Br J Cancer 114, 151–162 (2016)CrossRefPubMed

go back to reference A. Lempiainen, K. Hotakainen, C. Blomqvist, H. Alfthan, U.H. Stenman, Increased human chorionic gonadotropin due to hypogonadism after treatment of a testicular seminoma. Clin Chem 53, 1560–1561 (2007)CrossRefPubMed A. Lempiainen, K. Hotakainen, C. Blomqvist, H. Alfthan, U.H. Stenman, Increased human chorionic gonadotropin due to hypogonadism after treatment of a testicular seminoma. Clin Chem 53, 1560–1561 (2007)CrossRefPubMed

go back to reference P. Albers, W. Albrecht, F. Algaba, C. Bokemeyer, G. Cohn-Cedermark, K. Fizazi, A. Horwich, M.P. Laguna, N. Nicolai, J. Oldenburg, European Association of Urology, Eur Urol 68, 1054–1068 (2015)CrossRefPubMed P. Albers, W. Albrecht, F. Algaba, C. Bokemeyer, G. Cohn-Cedermark, K. Fizazi, A. Horwich, M.P. Laguna, N. Nicolai, J. Oldenburg, European Association of Urology, Eur Urol 68, 1054–1068 (2015)CrossRefPubMed

go back to reference K.P. Dieckmann, M. Spiekermann, T. Balks, I. Flor, T. Loning, J. Bullerdiek, G. Belge, MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours. Br J Cancer 107, 1754–1760 (2012)CrossRefPubMedPubMedCentral K.P. Dieckmann, M. Spiekermann, T. Balks, I. Flor, T. Loning, J. Bullerdiek, G. Belge, MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours. Br J Cancer 107, 1754–1760 (2012)CrossRefPubMedPubMedCentral

go back to reference K.P. Dieckmann, M. Spiekermann, T. Balks, R. Ikogho, P. Anheuser, W. Wosniok, T. Loening, J. Bullerdiek, G. Belge, MicroRNA miR-371a-3p - a novel serum biomarker of testicular germ cell tumors: Evidence for specificity from measurements in testicular vein blood and in neoplastic hydrocele fluid. Urol Int 97, 76–83 (2016)CrossRefPubMed K.P. Dieckmann, M. Spiekermann, T. Balks, R. Ikogho, P. Anheuser, W. Wosniok, T. Loening, J. Bullerdiek, G. Belge, MicroRNA miR-371a-3p - a novel serum biomarker of testicular germ cell tumors: Evidence for specificity from measurements in testicular vein blood and in neoplastic hydrocele fluid. Urol Int 97, 76–83 (2016)CrossRefPubMed

go back to reference M.J. Murray, D.J. Halsall, C.E. Hook, D.M. Williams, J.C. Nicholson, N. Coleman, Identification of microRNAs from the miR-371~373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors. Am J Clin Pathol 135, 119–125 (2011)CrossRefPubMed M.J. Murray, D.J. Halsall, C.E. Hook, D.M. Williams, J.C. Nicholson, N. Coleman, Identification of microRNAs from the miR-371~373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors. Am J Clin Pathol 135, 119–125 (2011)CrossRefPubMed

go back to reference M.J. Murray, E. Bell, K.L. Raby, M.A. Rijlaarsdam, A.J. Gillis, L.H. Looijenga, H. Brown, B. Destenaves, J.C. Nicholson and N. Coleman, A pipeline to quantify serum and cerebrospinal fluid micrornas for diagnosis and detection of relapse in paediatric malignant germ-cell tumours. Br J Cancer 114, 151-162 (2015) M.J. Murray, E. Bell, K.L. Raby, M.A. Rijlaarsdam, A.J. Gillis, L.H. Looijenga, H. Brown, B. Destenaves, J.C. Nicholson and N. Coleman, A pipeline to quantify serum and cerebrospinal fluid micrornas for diagnosis and detection of relapse in paediatric malignant germ-cell tumours. Br J Cancer 114, 151-162 (2015)